Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus.
暂无分享,去创建一个
F. Zannad | P. Böhme | B. Guerci | P. Drouin | A. Kearney-Schwartz | A. Kearney‐Schwartz | Bruno Guerci | Philip Böhme | Pierre Drouin
[1] S. Jackson,et al. The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes. , 2001, Atherosclerosis.
[2] L. Lerman,et al. Simvastatin Preserves Coronary Endothelial Function in Hypercholesterolemia in the Absence of Lipid Lowering , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[3] C. Dessy,et al. Hydroxy-Methylglutaryl–Coenzyme A Reductase Inhibition Promotes Endothelial Nitric Oxide Synthase Activation Through a Decrease in Caveolin Abundance , 2001, Circulation.
[4] L. Title,et al. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes: an effect prevented by vitamins C and E. , 2000, Journal of the American College of Cardiology.
[5] L. Lind,et al. The impairment in endothelial function induced by non-esterified fatty acids can be reversed by insulin. , 2000, Clinical science.
[6] S. Homma,et al. Acute Elevations of Plasma Asymmetric Dimethylarginine and Impaired Endothelial Function in Response to a High-Fat Meal in Patients With Type 2 Diabetes , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[7] T. Simoncini,et al. Raloxifene acutely stimulates nitric oxide release from human endothelial cells via an activation of endothelial nitric oxide synthase. , 2000, The Journal of clinical endocrinology and metabolism.
[8] L. Rodríguez-Mañas,et al. Treatment with acarbose may improve endothelial dysfunction in streptozotocin-induced diabetic rats. , 2000, Journal of cardiovascular pharmacology.
[9] J. Ritter,et al. Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with Type II diabetes , 2000, Diabetologia.
[10] N. Doba,et al. Close relationship of abnormal glucose tolerance with endothelial dysfunction in hypertension. , 2000, Hypertension.
[11] G. King,et al. Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. , 2000, Diabetes.
[12] S. Jackson,et al. Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus. , 2000, Circulation.
[13] J. Jukema,et al. Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation: reversal after lipid-lowering therapy by atorvastatin. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[14] G. Schuler,et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. , 2000, The New England journal of medicine.
[15] J. Westerbacka,et al. Insulin therapy improves endothelial function in type 2 diabetes. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[16] P. Stumbo,et al. Resistance vessel endothelial function in healthy humans during transient postprandial hypertriglyceridemia. , 2000, The American journal of cardiology.
[17] G. Paolisso,et al. Chronic vitamin E administration improves brachial reactivity and increases intracellular magnesium concentration in type II diabetic patients. , 2000, The Journal of clinical endocrinology and metabolism.
[18] M. Hoenig,et al. Metformin improves vascular function in insulin-resistant rats. , 2000, Hypertension.
[19] P. Groop,et al. In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. , 1999, Diabetes care.
[20] F. Ohsuzu,et al. Endothelium-dependent flow-mediated vasodilation in the postprandial state in type 2 diabetes mellitus. , 1999, The American journal of cardiology.
[21] F. Logerfo,et al. The effect of hormonal replacement therapy on the vascular reactivity and endothelial function of healthy individuals and individuals with type 2 diabetes. , 1999, The Journal of clinical endocrinology and metabolism.
[22] F. Logerfo,et al. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. , 1999, Diabetes care.
[23] H. Bohlen,et al. Acute hyperglycemia depresses arteriolar NO formation in skeletal muscle. , 1999, American journal of physiology. Heart and circulatory physiology.
[24] K. Tan,et al. Influence of low density lipoprotein (LDL) subfraction profile and LDL oxidation on endothelium-dependent and independent vasodilation in patients with type 2 diabetes. , 1999, The Journal of clinical endocrinology and metabolism.
[25] B. Guerci,et al. Increased ability of LDL from normolipidemic type 2 diabetic women to generate peroxides. , 1999, Clinical chemistry.
[26] W. Sheu,et al. Endothelial dysfunction is not reversed by simvastatin treatment in type 2 diabetic patients with hypercholesterolemia. , 1999, Diabetes care.
[27] M. Carrier,et al. Endothelial cell dysfunction and the pathogenesis of diabetic macroangiopathy , 1999, Diabetes/metabolism research and reviews.
[28] K. Kugiyama,et al. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. , 1999, Journal of the American College of Cardiology.
[29] M. Taskinen,et al. Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants. , 1999, Diabetes care.
[30] D. Green,et al. Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. , 1999, Journal of the American College of Cardiology.
[31] J. Cockcroft,et al. Effect of oral vitamin E (α‐tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus , 1999, Diabetic medicine : a journal of the British Diabetic Association.
[32] D. Rader,et al. A novel endothelial-derived lipase that modulates HDL metabolism , 1999, Nature Genetics.
[33] M. Carrier,et al. Pharmacology: Pharmacological Modulation of Endothelial Function by Insulin in the Rat Aorta , 1998, The Journal of pharmacy and pharmacology.
[34] F. Logerfo,et al. Estrogen improves endothelial function. , 1998, Journal of vascular surgery.
[35] Farris K. Timimi,et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. , 1998, Circulation.
[36] K. Kugiyama,et al. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation. , 1998, Atherosclerosis.
[37] E. Fleck,et al. Human cardiac microvascular and macrovascular endothelial cells respond differently to oxidatively modified LDL. , 1998, Atherosclerosis.
[38] A. Nitenberg,et al. Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors. , 1998, Circulation.
[39] N. Benda,et al. Preserved Endothelial Function in IDDM Patients, but Not in NIDDM Patients, Compared With Healthy Subjects , 1998, Diabetes Care.
[40] G. Plotnick,et al. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vasoactivity following a single high-fat meal. , 1997, JAMA.
[41] A. Heagerty,et al. Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hypercholesterolemic patients: a double-blind placebo-controlled study. , 1997, Circulation.
[42] A. Quyyumi,et al. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. , 1997, Circulation.
[43] D. Playford,et al. Low‐density lipoprotein size, high‐density lipoprotein concentration, and endothelial dysfunction in non‐insulin‐dependent diabetes , 1997, Diabetic medicine : a journal of the British Diabetic Association.
[44] A. Bist,et al. Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[45] S. Coppack,et al. Endothelial Dysfunction: Cause of the Insulin Resistance Syndrome , 1997, Diabetes.
[46] A. Baron,et al. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. , 1997, The Journal of clinical investigation.
[47] B. Williams,et al. Factors regulating the expression of vascular permeability/vascular endothelial growth factor by human vascular tissues , 1997, Diabetologia.
[48] C. Cobelli,et al. Forearm Nitric Oxide Balance, Vascular Relaxation, and Glucose Metabolism in NIDDM Patients , 1997, Diabetes.
[49] A. Dart,et al. Non-specific inhibition by human lipoproteins of endothelium dependent relaxation in rat aorta may be attributed to lipoprotein phospholipids. , 1997, Cardiovascular research.
[50] H. Maegawa,et al. Oxidized lipoproteins found in patients with NIDDM stimulate radical-induced monocyte chemoattractant protein-1 mRNA expression in cultured human endothelial cells , 1997, Diabetologia.
[51] A. Zeiher,et al. Oxidized low-density lipoprotein induces apoptosis of human endothelial cells by activation of CPP32-like proteases. A mechanistic clue to the 'response to injury' hypothesis. , 1997, Circulation.
[52] G. Watts,et al. Preserved endothelial function in patients with severe hypertriglyceridemia and low functional lipoprotein lipase activity. , 1997, Journal of the American College of Cardiology.
[53] M. Adams,et al. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[54] N. Hoogerbrugge,et al. Hypertriglyceridemia Enhances Monocyte Binding to Endothelial Cells in NIDDM , 1996, Diabetes Care.
[55] R. Marfella,et al. Metformin Improves Hemodynamic and Rheological Responses to L-Arginine in NIDDM Patients , 1996, Diabetes Care.
[56] T. Lüscher,et al. Lipids and endothelial function: effects of lipid-lowering and other therapeutic interventions , 1996, Current opinion in lipidology.
[57] A. Kashiwagi,et al. Glycation, Oxidative Stress, and Scavenger Activity: Glucose Metabolism and Radical Scavenger Dysfunction in Endothelial Cells , 1996, Diabetes.
[58] A. Baron,et al. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. , 1996, The Journal of clinical investigation.
[59] H. Hobbs,et al. Expression of the VLDL receptor in endothelial cells. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[60] M. Creager,et al. -.____----.---_-Impaired Nitric Oxide-Mediated Vasodilation in Patients With Non-Insulin-Dependent Diabetes Mellitw , 2016 .
[61] M. Mattson,et al. Linoleic acid activates nuclear transcription factor-kappa B (NF-kappa B) and induces NF-kappa B-dependent transcription in cultured endothelial cells. , 1996, The American journal of clinical nutrition.
[62] A. Baron. The Coupling of Glucose Metabolism and Perfusion in Human Skeletal Muscle: The Potential Role of Endothelium-Derived Nitric Oxide , 1996, Diabetes.
[63] Farris K. Timimi,et al. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. , 1996, The Journal of clinical investigation.
[64] A. Shore,et al. Microvascular Function in Type 2 (Non‐insulin‐dependent) Diabetes: Improved Vasodilation After One Year of Good Glycaemic Control , 1995, Diabetic medicine : a journal of the British Diabetic Association.
[65] B. Egan,et al. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. , 1995, Hypertension.
[66] J. Liao,et al. Regulation of G-protein alpha i2 subunit expression by oxidized low-density lipoprotein. , 1995, The Journal of clinical investigation.
[67] W. Weintraub,et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. , 1995, The New England journal of medicine.
[68] J. Liao,et al. Oxidized Low-density Lipoprotein Decreases the Expression of Endothelial Nitric Oxide Synthase (*) , 1995, The Journal of Biological Chemistry.
[69] N. Fineberg,et al. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. , 1994, The Journal of clinical investigation.
[70] A. Baron,et al. Hemodynamic actions of insulin. , 1994, The American journal of physiology.
[71] D. Harrison,et al. Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[72] B. Tesfamariam. Free radicals in diabetic endothelial cell dysfunction. , 1994, Free radical biology & medicine.
[73] S. Lillioja,et al. Interstitial insulin concentrations determine glucose uptake rates but not insulin resistance in lean and obese men. , 1994, The Journal of clinical investigation.
[74] E. Levin,et al. Insulin Stimulates Production and Secretion of Endothelin From Bovine Endothelial Cells , 1993, Diabetes.
[75] A. Donker,et al. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus , 1992, The Lancet.
[76] R. Cohen,et al. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. , 1992, The American journal of physiology.
[77] T. Lüscher,et al. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from human and porcine endothelium. , 1992, Circulation research.
[78] A. Rose,et al. Human coronary microvessels in diabetes and ischaemia. Morphometric study of autopsy material , 1992, The Journal of pathology.
[79] B. Hoffman,et al. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. , 1992, The Journal of clinical investigation.
[80] R. Cohen,et al. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. , 1991, The Journal of clinical investigation.
[81] K. Tracey,et al. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. , 1991, The Journal of clinical investigation.
[82] K. Kugiyama,et al. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins , 1990, Nature.
[83] L. Edvinsson,et al. Vasomotor changes in isolated coronary arteries from diabetic rats. , 1988, Acta physiologica Scandinavica.
[84] D. Godin,et al. Alterations in Free Radical Tissue-Defense Mechanisms in Streptozocin-Induced Diabetes in Rat: Effects of Insulin Treatment , 1987, Diabetes.